Chronic Heart Failure: Contemporary Diagnosis and Management
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · cited 1×
“Obesity, defined as a body mass index greater than 30 kg/ m(2), is increasingly being recognized as an independent risk factor for heart failure.(18) Obesity leads to alterations in LV chamber size and mass, which may progress over time to systolic and diastolic dysfunction.”
BackgroundThe effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546 · cited 1×
“Device therapy adds incremental benefit in patients with systolic heart failure or in those who remain ill after receiving medical therapy and can be used to prevent a crisis such as a sudden arrhythmic event.(89) Mechanical dyssynchrony, defined as nonsynchronous contraction between the walls of the left ventricle (i…”
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173 · cited 2×
“Exercise was safe, improved patients’ sense of well-being, and correlated with a trend toward mortality reduction.(87,88) Maximal changes in 6-minute walk distance were evident at 3 months, but the effects were durable, with significant improvements in cardiopulmonary exercise time and peak oxygen consumption persisti…”
BackgroundThe progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155 · cited 1×
“Although the relative risk of developing heart failure is modest, the sheer prevalence renders it a cause in approximately one-third of cases, giving it a high population-attributable risk.(12) In this regard, this risk marker serves as a most viable target for preventive therapy.”
BackgroundIrbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633 · cited 1×
“the coMBination of hydRalazine and nitRates should Be liMited to sPecial PoPulations: those Patients Who ReMain hyPeRtensive With neuRohoRMonal Blockade and those With Renal insufficiency PRohiBiting use of aceis oR aRBs Hydralazine produces arterial vasodilatation and systemic vascular resistance reduction via modula…”
Rhythm control versus rate control for atrial fibrillation and heart failure
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708789 · Cited by 1,585
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
Packer, M., Poole-Wilson, P. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Rydén, L., Thygesen, K., & Uretsky, B. F. (1999) · Circulation · doi:10.1161/01.cir.100.23.2312 · Cited by 1,244
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051001 · Cited by 1,189 · cited 1×
“However, no firm data support improved survival with treatment.(83)”
BackgroundHe, J., Ogden, L. G., Bazzano, L. A., Vupputuri, S., Loria, C., & Whelton, P. K. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.7.996 · Cited by 1,172 · cited 2×
“Coronary artery disease (CAD) accounts for the vast majority of cases of systolic heart failure in the United States, followed by hypertensive and dilated cardiomyopathies.(10) In the acute setting of newly diagnosed cardiomyopathy, the exclusion of underlying CAD and potential “at-risk” myocardium that might benefit…”
BackgroundPredictors of congestive heart failure in the elderly: the Cardiovascular Health Study
Gottdiener, J. S., Arnold, A. M., Aurigemma, G. P., Polak, J. F., Tracy, R. P., Kitzman, D. W., Gardin, J. M., Rutledge, J. E., & Boineau, R. C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00582-9 · Cited by 907
Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome
Alpert, M. A. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200104000-00003 · Cited by 795 · cited 1×
“Obesity leads to alterations in LV chamber size and mass, which may progress over time to systolic and diastolic dysfunction.(19) Intentional weight loss may lead to regression of some of these structural changes and is generally advisable.”
BackgroundFlynn, K. E., Piña, I. L., Whellan, D. J., Lin, L., Blumenthal, J. A., Ellis, S. J., Fine, L. J., Howlett, J. G., Keteyian, S. J., Kitzman, D. W., et al. (2009) · JAMA · doi:10.1001/jama.2009.457 · Cited by 737
Influence of Obstructive Sleep Apnea on Mortality in Patients With Heart Failure
Wang, H., Parker, J. D., Newton, G. E., Floras, J. S., Mak, S., Chiu, K.-L., Ruttanaumpawan, P., Tomlinson, G., & Bradley, T. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.046 · Cited by 616
Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation · doi:10.1161/circulationaha.106.628347 · Cited by 605
Obesity and suppressed B-type natriuretic peptide levels in heart failure
Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., & Frohlich, E. D. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.066 · Cited by 534 · cited 1×
“Comorbid conditions must be taken into account because renal insufficiency increases these levels and obesity lowers them.(8,9) The etiology of systolic heart failure dramatically affects prognosis and treatment.”
BackgroundSelf-citationGoldstein, R. E., Boccuzzi, S. J., Cruess, D., & Nattel, S. (1991) · Circulation · doi:10.1161/01.cir.83.1.52 · Cited by 521
Taylor, D. O., Edwards, L. B., Aurora, P., Christie, J. D., Dobbels, F., Kirk, R., Rahmel, A. O., Kucheryavaya, A. Y., & Hertz, M. I. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.06.017 · Cited by 346
Alpert, M. A., Terry, B. E., Mulekar, M., Cohen, M. V., Massey, C. V., Fan, T. M., Panayiotou, H., & Mukerji, V. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00505-5 · Cited by 325
Anemia predicts mortality in severe heart failure
Mozaffarian, D., Nye, R., & Levy, W. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00425-x · Cited by 294
Chow, T., Kereiakes, D. J., Onufer, J., Woelfel, A., Gursoy, S., Peterson, B. J., Brown, M. L., Pu, W., & Benditt, D. G. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.018 · Cited by 201
Auricchio, A., Kloss, M., Trautmann, S. I., Rodner, S., & Klein, H. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02200-7 · Cited by 99 · cited 1×
“Early studies showed improved exercise capacity, reduction in symptoms, and evidence of reverse remodeling.(90) The CARE-HF (Cardiac Resynchronization in Heart Failure Study) trial was the first study to demonstrate a statistically significant reduction in all-cause mortality with CRT placement.”
Background
Cited by
Shumba, A.-T., Montanaro, T., Sergi, I., Bramanti, A., Ciccarelli, M., Rispoli, A., Carrizzo, A., De Vittorio, M., & Patrono, L. (2023) · Sensors · doi:10.3390/s23156896 · Cited by 74
Metadata
- Authors
- Ramani, G. V., Uber, P. A., & Mehra, M. R.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 85
- Issue
- 2
- Pages
- 180-195
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2075283117
- Cited by
- 236
- References
- 42
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.